Biomaterials for Drug Delivery: Recent Advances and Discoveries
A special issue of Materials (ISSN 1996-1944). This special issue belongs to the section "Biomaterials".
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 572
Special Issue Editor
Interests: biomaterials; biomedical polymers; nanopharmacy, nanomedicine; biodegradable and bioresorbable polymers; drug delivery systems; drug carriers; polymeric implantable materials; polymers in tissue engineering; controlled drugs release;
Special Issue Information
Dear Colleagues,
In the last two decades, the biomaterials field has progressed tremendously. One of the most interesting areas of biomaterial engineering is drug-delivery system (DDS) technology, including liposomes, nano- or microparticles, microspheres, gels, prodrugs, dendrimers, cyclodextrins, composite carriers and others. It is commonly known that by developing a variety of DDSs, it is now possible to better control the pharmacokinetics, pharmacodynamics, toxicity, immunogenicity and efficacy of drugs. To date, many polymeric, ceramic, carbon and composite DDSs have been investigated. However, only a few are currently used in commercial products. The main problem with the DDSs obtained to date probably lies in the lack of full control of drug release. This Special Issue aims to identify and review the latest biomaterials for drug delivery, which can potentially be used in oncology, cardiology, neurodegenerative diseases, etc.
Dr. Marcin Sobczak
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Materials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Biomaterials
- Drug carriers
- Drug-delivery systems
- Polymeric biomaterials
- Ceramic biomaterials
- Carbon biomaterials
- Composite biomaterials
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
